THE SCALE and speed of the vaccine rollout in the UK has been breathtaking but vaccination fears do persist. AstraZeneca's coronavirus vaccine has been mired in reports that link it to blood clots. The latest Medicines and Healthcare products Regulatory Agency guidance breaks down the risk of developing a blood clot post-vaccination by age.
You Can See More: AstraZeneca vaccine: Risk of developing blood clots broken down by age - MHRA latest
The following article AstraZeneca vaccine: Risk of developing blood clots broken down by age - MHRA latest is courtesy of Daily Express :: Health Feed
THE SCALE and speed of the vaccine rollout in the UK has been breathtaking but vaccination fears do persist. AstraZeneca's coronavirus vaccine has been mired in reports that link it to blood clots. The latest Medicines and Healthcare products Regulatory Agency guidance breaks down the risk of developing a blood clot post-vaccination by age.
THE SCALE and speed of the vaccine rollout in the UK has been breathtaking but vaccination fears do persist. AstraZeneca's coronavirus vaccine has been mired in reports that link it to blood clots. The latest Medicines and Healthcare products Regulatory Agency guidance breaks down the risk of developing a blood clot post-vaccination by age.
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.